Careers

Head, Intellectual Property

The Head, Intellectual Property is a leadership position responsible for all aspects of Cullinan’s intellectual property portfolio.

Company

Cullinan Oncology, Inc. is a publicly traded (Nasdaq: CGEM) biopharmaceutical company advancing a growing and diversified portfolio of innovative, early-stage clinical therapeutic assets, by capitalizing on the latest scientific breakthroughs. They combine a unique portfolio model, with innovative sourcing techniques and drug development expertise, to discover and advance candidates for potentially transformative oncology drugs.

Cullinan is currently advancing a portfolio of eight oncology programs, including three clinical-stage programs. Its lead program, CLN-081, showed encouraging efficacy and safety data in an ongoing Phase 1/2a trial, and recently received Breakthrough Therapy Designation from the FDA. The company completed an IPO in early 2021 and currently has $430.9 million of cash and investments on hand as of December 31, 2021.

Cullinan uniquely applies open innovation to the development of scientific oncology assets. Their approach breaks down silos, encourages new ways of thinking and collaboration, and ultimately turns ideas, and inspiration into novel, executable, therapeutic concepts. Through both internal and external means, they seek to develop assets that have the potential to dramatically improve the lives of those living with cancer.

Their strategy is to build a pipeline of therapeutic candidates, across small molecules and biologics, with a focus on assets that they believe have novel technology, employ differentiated mechanisms, are in more advanced stages of development than competing candidates, or have a combination of these attributes.

Position

The Head, Intellectual Property is a leadership position responsible for all aspects of Cullinan’s intellectual property portfolio.  The role will report to the Chief Legal Officer, Chief Compliance Officer and Corporate Secretary and will partner directly with senior management and advise the Board of Directors.  The person in this role will provide expert analysis and counsel on life sciences intellectual property issues including patent prosecution and issues arising in general commercial contracts and strategic corporate transactions including international and cross-border transactions.  The person in this role will lead in setting strategy for the company’s patent and trademark portfolio and will provide advice with respect to the competitive landscape.  Finally, the role is responsible for managing any intellectual property litigation and anticipating and guarding against intellectual property legal risks facing the company.

Other key responsibilities of the Head, Intellectual Property position include:

  • Managing outside counsel in connection with patent prosecution and intellectual property litigation matters
  • Advising on intellectual property issues arising in corporate transactions such as acquisitions and divestitures, joint ventures and collaboration and partnership agreements
  • Drafting, negotiating and reviewing license agreements
  • Providing analysis and counsel on intellectual property issues including due diligence with regard to proposed new products and services and commercial transactions
  • Monitoring and analyzing changes to intellectual property laws and regulations to ensure continued company compliance and advising senior management accordingly
  • Presenting to senior management and Board of Directors on intellectual property matters
  • Other responsibilities in the IP sphere, as requested

Job Requirements

The following are minimum requirements related to the Head, Intellectual Property position:

  • Bachelor’s degree (B.A. /B.S.) (Ph.D. preferred) and Juris Doctor or equivalent from an accredited law school in the US or equivalent common law degree.  A current license as an attorney qualified to practice law in Massachusetts or license to practice law in another applicable jurisdiction with the ability to obtain an in-house counsel license in Massachusetts. Registration as a licensed U.S Patent Attorney.
  • 10 years of related experience (preferably in a combination of law firm and in-house corporate settings) with significant focus in patent law
  • Significant experience with patent prosecution; (biologics and small molecule experience preferred)
  • Significant experience leading complex IP diligence to support life science technology licensing and M&A, and experience advising on IP issues in contracts of all kinds
  • Strong interpersonal skills, team player, effective communicator
  • Ability to effectively manage multiple projects simultaneously
  • Ability to effectively communicate legal and compliance issues verbally and in writing in a clear and understandable manner to all levels of the organization
  • Approximately 50% in office time at the company’s headquarters in Cambridge, MA
  • An equivalent combination of education and experience may be accepted as a satisfactory substitute for the specific education and experience listed above

Cullinan Oncology is proud to be an Equal Opportunity Employer. We are committed to creating an inclusive and diverse environment for all employees and applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

Senior Clinical Trial Manager

Cullinan Oncology is seeking an individual to facilitate and support the clinical protocol development process in collaboration with the Medical Director / Clinical Scientist.

The Company

Cullinan Oncology is dedicated to creating new standards of care for patients with cancer.

We innovate without borders to find the most promising clinic-ready cancer therapies, whether from our own discovery efforts or through exceptional engagement with our academic and industry partners.

Anchored in a deep understanding of immuno-oncology and translational cancer medicine, we leverage our scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and select the optimal modality to develop transformative therapeutics across cancer indications.

Powered by our novel research model, we push conventional boundaries from candidate selection to cancer therapeutic, applying rigorous early experimentation to fast-track only the most promising assets to the clinic and ultimately commercialization.

As a result, our diversified pipeline is strategically built with assets that activate the immune system or inhibit key oncogenic drivers across a wide range of modalities, each with the potential to be the best or first in their class.

Our people possess deep scientific expertise, seek innovation openly, and exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients with cancer.

Job Title: Snr Clinical Trial Manager

Job Summary:

  • Facilitate and support the clinical protocol development process in collaboration with the Medical Director / Clinical Scientist.
  • Drive and/or contribute to the development of trial-related documents and processes.
  • Lead the development of study tools, guidelines, and training materials to support effective and accurate execution of clinical trial activities
  • Directly manage CRO partners and other vendors, as well as developing relationships with Investigators and Site Staff to ensure the optimal execution of a clinical trial
  • Manage all aspects of clinical studies from study start-up to CSR, including timeline generation & maintenance in line with corporate goals, regulatory documents, budget, and clinical trial agreements.
  • Participate in the ongoing review and cleaning of the clinical trial data.
  • Chair study team meetings, collecting input from all functional lines.
  • Participate in site identification, attending PSVs and SIVs as necessary.
  • Manage tracking, logistics and quality operations for biological samples supporting clinical trials from collection to analysis ensuring that sample inventories are accurate, complete, and up to date through effective interactions with internal teams, sites, central reference labs, specialty lab partners, external collaborators (e.g., Academia) and third-party vendors
  • Ensure ongoing management of patient enrollment
  • Ensure compliance with patient consent for collection and intended use, destruction, storage and/or future, post-study use of biological samples
  • Communicate with snr management to ensure transparency throughout the course of the trial(s) regarding study metrics and overall status
  • Participate in process improvement projects (as necessary)
  • Work independently as a senior associate
  • Opportunity to mentor junior staff through the trial process

Primary Job Requirements:

  • BA/BS degree
  • At least years of 5 years biotech/pharmaceutical industry experience preferred.

Skills and competencies

  • Advanced skills in Microsoft Office programs as well as good working knowledge of electronic data systems
  • Detail oriented, have precise record keeping skills, as well as the ability to track and resolve issues
  • Excellent teamwork, communication (verbal and written), organizational, and interpersonal skills
  • Self-motivated, proactive, and able to prioritize and manage multiple projects simultaneously
  • Comfortable working in a dynamic environment in a rapidly growing company with several exciting and expanding clinical development programs 

Cullinan Oncology is proud to be an Equal Opportunity Employer. We are committed to creating an inclusive and diverse environment for all employees and applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

Manager, Financial Planning & Analysis (FP&A)

Cullinan Oncology is seeking a finance professional with strong business partnering, financial, analytical, and communication skills.

Location: Cambridge, MA (Hybrid/Remote available)

Reports to: VP of FP&A and Strategic Finance

Company Summary:
Cullinan Oncology, Inc, (Cullinan) is a biopharmaceutical company dedicated to creating new standards of care for patients with cancer. We innovate without borders to find the most promising clinic-ready cancer therapies, whether from our own discovery efforts or through exceptional engagement with our academic and industry partners. Anchored in a deep understanding of immuno-oncology and translational cancer medicine, we leverage our scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and select the optimal modality to develop transformative therapeutics across cancer indications. Powered by our novel research model, we push conventional boundaries from candidate selection to cancer therapeutic, applying rigorous early experimentation to fast-track only the most promising assets to the clinic and ultimately commercialization. As a result, our diversified pipeline is strategically built with assets that activate the immune system or inhibit key oncogenic drivers across a wide range of modalities, each with the potential to be the best or first in their class.

Our people possess deep scientific expertise, seek innovation openly, and exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients with cancer. Learn more about our Company at www.cullinanoncology.com, and follow us on LinkedIn and Twitter.

Our pipeline currently includes three clinical-stage candidates and five preclinical programs. We are evaluating our lead candidate, CLN-081, in a Phase 1/2a trial in patients with non-small cell lung cancer, or NSCLC, harboring EGFRex20ins mutations who have previously received platinum-based chemotherapy. In January 2022, we announced that the FDA granted CLN-081 Breakthrough Therapy Designation (BTD). In June 2022, we completed a strategic collaboration with Taiho Oncology to jointly develop CLN-081 and share profits 50/50 in the U.S. Our two other clinical stage programs include CLN-049, a bispecific T cell-engaging antibody targeting FLT3 and CD3 that is in an ongoing clinical trial for patients with relapsed or refractory, or r/r, AML; and CLN-619, a monoclonal antibody designed to stimulate natural killer, or NK, and T cell responses by engaging a unique target, MICA/B. Our pre-clinical pipeline includes two programs in IND-enabling studies, CLN-617 and CLN-978, and three programs in research.

Our strategy is to source innovation through both internal discovery efforts and external collaborations, focusing on advanced stage assets with novel technology platforms and differentiated mechanisms. Before we advance a product candidate into clinical development, we evaluate its potential for anti-tumor activity as a single agent as well as its ability to generate an immune system response or to inhibit oncogenic drivers. Using this strategy, we have efficiently developed or in-licensed a portfolio of therapeutic candidates that currently includes eight distinct programs.

Position Summary:
Cullinan Oncology is seeking a finance professional with strong business partnering, financial, analytical, and communication skills. In this role, you will be responsible for key corporate planning that will support executive decision making. You will be a key business partner for our G&A leadership team and select key R&D leadership teams, helping to shape the early-stage portfolio and assisting Finance, HR, IT, and Communications on critical, corporate-changing initiatives.

We are seeking a finance professional who conducts insightful financial analyses, manages the manage short- and long-term P&L, and has experience working with executive management, all within a clinical-stage biotechnology company. The ideal candidate has a versatile skillset and has demonstrated agility in taking on new roles and responsibilities.

If you thrive in an entrepreneurial and collegial working environment, the FP&A position represents a unique opportunity to join a dynamic company on the verge of substantial growth. This position will report to the VP of Strategic Finance.

Key FP&A Responsibilities:

  • Build annual operating budgets for G&A departments and select R&D departments, including Biologics Research and Small Molecule Research
  • Conduct quarterly business reviews, including actual vs budget and vs prior forecast analyses and reports
  • Update rolling 24-month forecast
  • Develop management reports to explain variances and provide financial insight to drive strategic and operational decision making

Key Business Partnership Responsibilities:

  • Develop executive summary presentations and manage monthly reporting and analysis packages to support strategic decision-making
  • Partner closely with G&A/R&D functions to drive enterprise-level financial planning, headcount planning, and strategic planning
  • Maintain and improve financial models and reports that track and analyze functional costs and their impact on the company’s overall performance
  • Drive reporting, forecasting, and process improvements, including developing reports for trending and analysis of specific business objectives
  • Lead quarterly enterprise risk planning and mitigation to determine most critical business risks and mitigation plans

Required Qualifications:

  • Bachelor’s degree or higher in Business, Finance, or Accounting
  • >4 years of life sciences industry experience
  • Experience at a publicly listed company that issues external guidance
  • Ability to lead internal teams and partner with external consultants, accountants, auditors, etc.
  • Ability to work in a fast-paced environment and manage well through ambiguity and complexity
  • Strong written and verbal communication and presentation skills
  • Ability to work in a cross functional team environment across multiple senior levels of management

Preferred Qualifications:

  • MBA, CPA or CFA a plus
  • Masters degree in business, finance, and / or accounting

Cullinan Oncology offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes highly flexible vacation, medical, dental, vision, life insurance, equity incentives and 401k match.

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

(Associate-) (Senior-) Director, Clinical Research Scientist

The Director, Clinical Research Scientist participates in the development, strategic planning, and execution of clinical development programs in collaboration with other members of the clinical development team, including clinical operations, translational sciences, and regulatory affairs.

The Company

Cullinan Oncology is dedicated to creating new standards of care for patients with cancer.
We innovate without borders to find the most promising clinic-ready cancer therapies, whether from our own discovery efforts or through exceptional engagement with our academic and industry partners.

Anchored in a deep understanding of immuno-oncology and translational cancer medicine, we leverage our scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and select the optimal modality to develop transformative therapeutics across cancer indications.

Powered by our novel research model, we push conventional boundaries from candidate selection to cancer therapeutic, applying rigorous early experimentation to fast-track only the most promising assets to the clinic and ultimately commercialization.

As a result, our diversified pipeline is strategically built with assets that activate the immune system or inhibit key oncogenic drivers across a wide range of modalities, each with the potential to be the best or first in their class.

Our people possess deep scientific expertise, seek innovation openly, and exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients with cancer.

(Associate-)/(Senior-) Director, Clinical Research Scientist

The Director, Clinical Research Scientist participates in the development, strategic planning, and execution of clinical development programs in collaboration with other members of the clinical development team, including clinical operations, translational sciences, and regulatory affairs. The Clinical Research Scientist will play a substantial role in the development of clinical and regulatory documents, the review of scientific and clinical data, and the communication of data both within the company and to the outside scientific and medical audiences.

Key responsibilities of the role may include, but are not limited to:

Clinical Study Planning and Execution

  • Assists the VP of Clinical Development and/or Medical Director in formulating clinical development plans and study designs.
  • Participates in protocol training for site initiation and investigator meetings in collaboration with clinical operations.
  • Reviews and adjudicates study subject eligibility, protocol deviations, and responds to specific site protocol questions working closely with the medical monitor.
  • Identifies scientific and/or clinical quality issues to discuss with investigator and study sites and escalates as appropriate to the quality team to ensure compliance with GCP

Clinical Document Development

  • Leads development of clinical study synopses and protocols
  • Assists in the preparation of clinical content for regulatory submissions/documents.
  • Participates in publication planning
  • Participates and/or leads the development of internal and external presentations/publications (manuscripts, posters, etc.) of clinical study data

Clinical Data Review and Analysis

  • Works closely with biostatisticians and programmers to develop case report forms and to plan analyses of clinical data
  • Performs ongoing clinical data review and critical analysis of study data, partnering with the medical monitor and data management
  • Provides clinical science related contributions to development of case report forms (CRFs), CRF completion guidelines, and statistical analysis plans

Qualifications

  • Advanced degree in life sciences and/or health related field, with 5+ years of drug development experience or bachelor’s level education with relevant working experience will also be considered
  • Basic knowledge and understanding of the medical oncology and/or hematology therapeutic area
  • Strong understanding of Good Clinical Practice, the drug development process, and design and conduct of clinical studies
  • Excellent written and verbal communication skills
  • Ability to interact with staff at all levels to coordinate and execute study activities in a face-paced small biotech environment

Location
This position can be performed at our headquarters in Cambridge, MA, or we will consider remote working arrangement depending on candidate experience.

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

Associate Director, FP&A and Strategic Finance

Cullinan Oncology is seeking a finance professional with strong business partnering, financial, analytical, and communication skills.

Location: Cambridge, MA (Hybrid/Remote available)

Reports to: VP of FP&A and Strategic Finance

Company Summary:
Cullinan Oncology, Inc, (Cullinan) is a biopharmaceutical company dedicated to creating new standards of care for patients with cancer. We innovate without borders to find the most promising clinic-ready cancer therapies, whether from our own discovery efforts or through exceptional engagement with our academic and industry partners. Anchored in a deep understanding of immuno-oncology and translational cancer medicine, we leverage our scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and select the optimal modality to develop transformative therapeutics across cancer indications. Powered by our novel research model, we push conventional boundaries from candidate selection to cancer therapeutic, applying rigorous early experimentation to fast-track only the most promising assets to the clinic and ultimately commercialization. As a result, our diversified pipeline is strategically built with assets that activate the immune system or inhibit key oncogenic drivers across a wide range of modalities, each with the potential to be the best or first in their class.

Our people possess deep scientific expertise, seek innovation openly, and exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients with cancer. Learn more about our Company at www.cullinanoncology.com, and follow us on LinkedIn and Twitter.

Our pipeline currently includes three clinical-stage candidates and five preclinical programs. We are evaluating our lead candidate, CLN-081, in a Phase 1/2a trial in patients with non-small cell lung cancer, or NSCLC, harboring EGFRex20ins mutations who have previously received platinum-based chemotherapy. In January 2022, we announced that the FDA granted CLN-081 Breakthrough Therapy Designation (BTD). In June 2022, we completed a strategic collaboration with Taiho Oncology to jointly develop CLN-081 and share profits 50/50 in the U.S. Our two other clinical stage programs include CLN-049, a bispecific T cell-engaging antibody targeting FLT3 and CD3 that is in an ongoing clinical trial for patients with relapsed or refractory, or r/r, AML; and CLN-619, a monoclonal antibody designed to stimulate natural killer, or NK, and T cell responses by engaging a unique target, MICA/B. Our pre-clinical pipeline includes two programs in IND-enabling studies, CLN-617 and CLN-978, and three programs in research.

Our strategy is to source innovation through both internal discovery efforts and external collaborations, focusing on advanced stage assets with novel technology platforms and differentiated mechanisms. Before we advance a product candidate into clinical development, we evaluate its potential for anti-tumor activity as a single agent as well as its ability to generate an immune system response or to inhibit oncogenic drivers. Using this strategy, we have efficiently developed or in-licensed a portfolio of therapeutic candidates that currently includes eight distinct programs.

Position Summary:
Cullinan Oncology is seeking a finance professional with strong business partnering, financial, analytical, and communication skills. In this role, you will be responsible for key corporate planning and finance activity that will support executive decision making. You will be a key business partner for our R&D leadership team, shaping portfolio management decisions on both internal and external programs.

Your efforts will be split into two areas, defined further in the job responsibilities: 1) Strategic Finance and 2) Business Partnerships. We are seeking a finance professional who understands corporate finance and valuation, conducts insightful financial analyses, manage short- and long-term P&L, and has experience working with executive management, all within a clinical-stage biotechnology company. The ideal candidate has a versatile skillset and has demonstrated agility in taking on new roles and responsibilities.

If you thrive in an entrepreneurial and collegial working environment, the Strategic Finance position represents a unique opportunity to join a dynamic company on the verge of substantial growth. This position will report to the VP of Strategic Finance.

Key Strategic Finance Responsibilities:

  • Support long-range planning by building and maintaining Cullinan’s 10-year corporate financial model, integrating a dynamic P&L forecast with balance sheet and cash flow statements
  • Develop revenue forecasts and valuation models for internal clinical and near-clinical stage programs
  • Support Business Development by developing revenue forecasts and valuation models for external licensing programs under evaluation
  • Manage cash flow forecasts for Cullinan’s entities and intra-entity cash requirements

Key FP&A Responsibilities:

  • Build annual operating budgets for R&D departments including Clinical, CMC / Technical Operations, and Research
  • Conduct quarterly business reviews, including actual vs budget and vs prior forecast analyses and reports
  • Update rolling 24 month forecast
  • Develop management reports to explain variances and provide financial insight to drive strategic and operational decision making

Key Business Partnership Responsibilities:

  • Develop executive summary presentations and manage monthly reporting and analysis packages to support strategic decision-making
  • Partner closely with R&D functions to drive enterprise-level financial planning, headcount planning, and strategic planning
  • Maintain and improve financial models and reports that track and analyze functional costs and their impact on the company’s overall performance
  • Drive reporting, forecasting, and process improvements, including developing reports for trending and analysis of specific business objectives
  • Lead quarterly enterprise risk planning and mitigation to determine most critical business risks and mitigation plans

Required Qualifications:

  • Bachelor’s degree or higher in Business, Finance, or Accounting
  • 8 years of life sciences industry experience
  • Experience at a publicly listed company that issues external guidance
  • Ability to lead internal teams and partner with external consultants, accountants, auditors, etc.
  • Excellent knowledge of corporate finance and US GAAP
  • Ability to work in a fast-paced environment and manage well through ambiguity and complexity
  • Strong written and verbal communication and presentation skills
  • Ability to work in a cross functional team environment across multiple senior levels of management

Preferred Qualifications:

  • MBA, CPA or CFA a plus
  • Masters degree in business, finance, and / or accounting

Cullinan Oncology offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes highly flexible vacation, medical, dental, vision, life insurance, equity incentives and 401k match.

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

Principal Scientist/Associate Director, Clinical Biomarker Lead

Cullinan Oncology is seeking an experienced Biomarker and Translational Sciences leader to join the Translational Research team.

The Company

Cullinan Oncology is dedicated to creating new standards of care for patients with cancer.

We innovate without borders to find the most promising clinic-ready cancer therapies, whether from our own discovery efforts or through exceptional engagement with our academic and industry partners.

Anchored in a deep understanding of immuno-oncology and translational cancer medicine, we leverage our scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and select the optimal modality to develop transformative therapeutics across cancer indications.

Powered by our novel research model, we push conventional boundaries from candidate selection to cancer therapeutic, applying rigorous early experimentation to fast-track only the most promising assets to the clinic and ultimately commercialization.

As a result, our diversified pipeline is strategically built with assets that activate the immune system or inhibit key oncogenic drivers across a wide range of modalities, each with the potential to be the best or first in their class.

Our people possess deep scientific expertise, seek innovation openly, and exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients with cancer.

Principal Scientist/Associate Director, Clinical Biomarker Lead

Cullinan Oncology is seeking an experienced Biomarker and Translational Sciences leader to join the Translational Research team. A successful incumbent would help integrate basic science research, proteomics, genomics and informatics to move programs into the clinic as well as leverage clinical findings to identify biomarkers and novel discovery opportunities for Cullinan’s extensive immune oncology pipeline.

  • Work closely with the preclinical group to define translational hypotheses, including potential pharmacodynamic and predictive biomarkers for novel immune oncology targets.
  • Design and implement bioanalytical, clinical biomarkers and exploratory translational strategies; adhere to clinical and regulatory submission protocols.
  • Successfully manage CROs and establish relationships to develop bioanalytical and biomarker assays, monitor assay qualification/validation at CROs, as well as bioanalytical/biomarker testing in the clinic.
  • Collaborate with clinical operations and the central lab to develop appropriate clinical laboratory manuals and to support sample management and logistics.
  • Perform integrative analysis of flow cytometry, gene expression, IHC/MultiplexIF data, and drug response data for baseline and post-dose biomarker discovery for clinical programs.
  • Drive decisions to support PK/PD, immunogenicity, and predictive biomarker analysis in clinical studies.
  • Ensure quality and timely submission of all clinical biomarker -related documents and materials for regulatory filings, including scientific advice filings, INDs, meeting briefing books, and other requests from global regulatory authorities.

Primary Job Requirements:

  • Ph.D. in Immuno-oncology, Immunology, Cancer Biology, or related field and 5 or more years of industry (biotech/pharmaceutical) clinical biomarker experience.
  • Deep understanding of the pre-clinical, translational, and clinical stages of drug development in the immune-oncology field.
  • Extensive working knowledge of biomarker and bioanalytical assay development and cutting-edge Omics methodologies in the clinic.
  • Hands-on experience with flow cytometry data analysis in clinical trials is required.

Skills and competencies

  • Experience leading within and collaborating effectively as a member of a cross-functional team.
  • Demonstrable knowledge of appropriate quality standards including ICH/GCP, and global regulations.
  • Experience in selection and management of external CROs.
  • Excellent analytical skills, with an ability to communicate complex issues in a simple way.
  • Ability to be agile and drive data-based decisions.

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

Program Leader (Director level), Biologics

The Program Leader will be responsible for overseeing one or more assets in Cullinan’s growing biologics portfolio.

Summary:

Cullinan Oncology is seeking a Program Leader to join the Development Team at Cullinan Oncology in Cambridge, MA. The Program Leader will be responsible for overseeing one or more assets in Cullinan’s growing biologics portfolio, which includes a diverse set of modalities (monoclonal antibodies, bispecific antibodies, fusion proteins, etc), targets, and mechanisms of action, with a heavy emphasis in the immuno-oncology space. The successful candidate will possess strong leadership skills, provide the needed guidance across functional areas, and be operationally minded with significant experience in drug development. The candidate will work in collaboration with an internal team, as well as in partnership with external collaborators, service providers, and consultants to advance development of the pipeline programs on time and on budget, while providing scientific rigor and expertise.

Responsibilities:

  • Serve as cross-functional Program Leader for preclinical/clinical biologics program(s)
  • Play lead role in crafting program strategy
  • Support the cross-functional team in development of timelines, planning and execution
  • Ensure alignment with project sub-teams and functional partners
  • Lead team in identifying program risks, mitigation and contingency plans
  • Prepare and track functional team budget including resources and costs, collaborating with finance and other cross-functional departments
  • Communicate, document and archive project team activities and decisions. Act as a primary contact for project team related information
  • Collaborate with legal team to develop IP strategy
  • Facilitate program and sub-team meetings, cross-functional communication and decision making, ensuring alignment with internal and external stakeholders
  • Identify, recommend and implement opportunities for streamlining / accelerating the program; identify key go/no-go program decision points
  • Lead the team in selecting CROs; manage external partners in overseeing studies, data analysis and reporting
  • Take lead role in crafting regulatory documents (e.g. IND’s), journal manuscripts, conference abstracts, and internal and external presentations
  • Participate in due diligence for inbound/outbound portfolio programs

Requirements:

  • Ph.D. in biology, biological engineering, oncology, immunology, or related field
  • At least 5 years of experience in the biotech/pharmaceutical industry
  • Experience leading preclinical/early development programs in oncology, preferably with focus in immuno-oncology
  • Deep understanding of the drug development process for biologics
  • Experience overseeing scientific teams, including management of external CROs
  • Strong interpersonal skills, ability to develop integral relationships with key stakeholders, strong conflict resolution skills
  • Excellent analytical skills, with an ability to communicate complex issues in a simple way
  • Experience with crafting regulatory documents, including INDs, and communications with regulatory authorities
  • Ability to translate strategy into action; strong communication, negotiation, and presentation skills
  • Proven track record of good decision making and exercising sound judgement
  • Results and detail-oriented; self-motivated
  • Driven to accelerate programs, with appropriate balance of risk taking
  • Highly collaborative with internal teams and external partners
  • Excellent written and oral communication skills
  • Ability to excel in a fast-paced environment

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

VP of Research

The VP of Research will be responsible for overseeing the early discovery portfolio.

Job Description: VP of Research

Hiring Manager: Jennifer Michaelson, Chief Development Officer, Biologics

Summary:

Cullinan Oncology is seeking a VP of Research to join Cullinan Oncology in Cambridge, MA. The VP of Research will be responsible for overseeing the early discovery portfolio, which includes a diverse set of modalities, targets, and mechanisms of action, with a heavy emphasis in the immuno-oncology space. The successful candidate will have deep experience in drug discovery and development, possess strong leadership skills, and have the ability to drive portfolio strategy as well as technical oversight of programs. The candidate will work in partnership with an internal team, as well as with Cullinan’s network of external collaborators, service providers, and consultants, to advance development of the pipeline programs on time and on budget, while providing scientific rigor and expertise. The VP of Research will also play a major role in refueling the pipeline with new programs, by participating in evaluation of external assets for in-licensing as well as bringing forth creative ideas for initiating new programs internally.

Responsibilities:

  • Oversee and manage discovery stage portfolio
  • Provide outstanding leadership in the management and advancement of multiple early stage programs
  • Partner with upper level management to devise overall strategy for early portfolio
  • Fuel the pipeline, including participation in due diligence of external assets for potential in-licensing and fostering innovative new ideas for programs to enter the Cullinan portfolio
  • Foster a high performing, collaborative, multi-disciplined team environment
  • Manage small team of internal scientists as well as network of scientists in Cullinan’s CRO network, plus external consultants
  • Provide technical insights and input for programs in the early portfolio
  • Lead team in highlighting program risks, developing timelines, and identifying key go/no go for portfolio programs
  • Collaborate with legal team to develop IP strategy
  • Oversee the team in selecting CROs, overseeing studies, data analysis and reporting
  • Forecast and manage budget and resource allocation for early portfolio

Requirements:

  • Ph.D. in biology, oncology, immunology, or related field
  • At least 10 years of experience in the biotech/pharmaceutical industry
  • Experience leading preclinical programs in oncology, preferably with focus in immuno-oncology
  • Deep understanding of the drug discovery and development process
  • Experience leading scientific teams, including selection and management of external CROs
  • Ability to be agile and drive data-driven decisions
  • Capable of quickly transitioning between strategic and tactical thinking
  • Creative and innovative in bringing new programs into the pipeline
  • Deep knowledge of in vitro assays and in vivo models in oncology/immuno-oncology
  • Collaborative leadership style; strong interpersonal skills
  • Excellent analytical skills, with an ability to communicate complex issues in a simple way
  • Ability to translate strategy into action; strong communication, negotiation, and presentation skills
  • Proven track record of good decision making and exercising sound judgement
  • Results and detail-oriented
  • Driven to accelerate programs, with appropriate balance of risk taking
  • Highly collaborative with internal teams and external partners
  • Experience directly managing and leading high performing teams, coaching and mentoring others to enhance performance and/or facilitate career progression
  • Excellent written and oral communication skills
  • Ability to excel in a fast-paced environment

Contact us for more information.

Name(Required)
Accepted file types: pdf, doc, docx, rtf, html, odt, Max. file size: 5 MB.
This field is for validation purposes and should be left unchanged.

Disclosures

Employment rights under federal law

Cullinan Oncology strives to be a diverse, inclusive organization that attracts and retains outstanding talent. There are a number of statutes and federal regulations enforced by agencies within the US Department of Labor that make it mandatory for employment notices to be posted in Cullinan’s workplace environment. The Department of Labor provides these required notices via electronic posters.

Equal Employment Opportunity (EEO)
Applicants to and employees of most private employers, state and local governments, educational institutions, employment agencies and labor organizations are protected under Federal law from discrimination because of ethnicity, race, creed, color, religion, sex (including pregnancy, childbirth or related medical conditions), national origin, immigration status, ancestry, age, marital status, protected veteran status, military status, disability, genetic information, medical condition, sexual orientation, gender identity, or any other basis prohibited under federal, state or local law.

EEO Equal Employment Opportunity is the Law

Family and Medical Leave Act (FMLA)
Provides an entitlement of up to 12 weeks of job-protected, unpaid leave during any 12-month period to eligible, covered employees for the following reasons: 1) birth and care of the eligible employee’s child, or placement for adoption or foster care of a child with the employee; 2) care of an immediate family member (spouse, child, parent) who has a serious health condition; or 3) when the employee is unable to work due to his or her own serious health condition.

Employee Rights under the Family and Medical Leave Act

Employee Polygraph Protection Act
Prohibits most private employers from using lie detector tests either for pre-employment screening or during the course of employment.

EPPA Employee Polygraph Protection Act

Benefits

At Cullinan Oncology, one of our highest priorities is addressing the health and welfare needs of our employees and their family members. To help our employees protect themselves and their family physically and financially, we are pleased to offer a robust benefits package which includes, but is not limited to: 401(k) Plan with 5% match, Medical, Dental, Vision, Healthcare Reimbursement Account, Short Term and Long Term Disability, Life and AD&D benefits, Wellness Perks, access to an Employee Assistance Program, Tuition Reimbursement, and an unlimited Vacation Policy.

Medical Plan Transparency in Coverage – Machine-Readable Files
This link leads to the machine readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine-readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.